High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Archives of Gynecology and Obstetrics

• Publication date

  2013-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00404-013-2885-xPMID 23700253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.

  2012cited by this paper
• Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.

  2011cited by this paper
• Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.

  2011cited by this paper
• The impact of HAART on HPV-related cervical disease.

  2010influential reference
• The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents

  2010cited by this paper
• Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.

  2009cited by this paper
• HPV screening for cervical cancer in rural India.

  2009cited by this paper
• HPV screening for cervical cancer in rural India.

  2009cited by this paper
• Cervical cancer prevention and the Millennium Development Goals.

  2008cited by this paper
• Adding Human Papillomavirus Testing to Cytology for Primary Cervical Cancer Screening: Shooting First and Asking Questions Later

  2008cited by this paper
• Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

  2008cited by this paper
• Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

  2008cited by this paper
• Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women

  2007cited by this paper
• Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

  2007cited by this paper
• Chapter 1: HPV in the etiology of human cancer.

  2006cited by this paper
• HPV in the etiology of human cancer

  2006cited by this paper
• Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA‐positive women with equivocal or mildly abnormal cytology

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

  2005cited by this paper
• Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

  2004cited by this paper
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective

  2004cited by this paper
• Antiretroviral therapy in adults and adolescents.

  2003cited by this paper
• Chapter 6: Immunosuppression and co-infection with HIV.

  2003cited by this paper
• Immunosuppression and co-infection with HIV

  2003cited by this paper
• The 2001 Bethesda System: terminology for reporting results of cervical cytology.

  2002cited by this paper
• Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.

  2001cited by this paper
• Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer.

  1999cited by this paper
• The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

  1998cited by this paper
• A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women.

  1998cited by this paper
• A comparison of goodness-of-fit tests for the logistic regression model.

  1997cited by this paper
• Prevention and Control of Nosocomial Infections in Spain: Current Problems and Future Trends

  1996cited by this paper
• Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.

  1995cited by this paper

• Multi-Target Molecular Detection of Sexually Transmitted Infections in Women Living with HIV in Northeastern Brazil

  2025influential citation
• Prevalence and risk factors of high-risk cervical HPV infections among women attending Debre Tabor hospital family planning and gynecology clinic, Northcentral Ethiopia

  2025cites this paper
• Molecular epidemiology of human papillomavirus genotypes among HIV-negative women and women living with HIV with cervical cancer in two regions in Nigeria

  2025cites this paper
• High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis

  2023cites this paper
• Molecular Genotyping of Human Papillomaviruses (HPV) in HIV+ and HIV− Women in Senegal

  2022cites this paper
• RARE PRESENTATION OF FLORID VULVA WARTS - A CASE REPORT AND REVIEW OF LITERATURE.

  2022cites this paper
• Prevalence and genotype specific concordance of oro-genital and anal human papillomavirus infections among sexually active Nigerian women

  2021cites this paper
• Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis

  2020cites this paper
• Barriers for Cervical Cancer Screening in Women Living with HIV: A Systematic Review

  2020cites this paper
• Increasing Cervical Cancer Screening in Hiv Positive Women by Introduction of a Provider Prompted Algorithm Tool: A Quality Improvement Project

  2018influential citation
• Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis

  2018cites this paper
• Sociodemographic determinants of abnormal cervical cytology among HIV positive women in Nnewi, Nigeria

  2017cites this paper
• Dissertation submitted in partial fulfillment of the requirements for the degree of Master of Science in Epidemiology in the college of Medicine and Health Science

  2017cites this paper
• Incidence of Cervical Cancer in Calabar, Nigeria

  2016cites this paper
• Measuring Knowledge of Cancer Screening and Prevention Strategies in HIV Healthcare Professionals.

  2016cites this paper
• Prevalence of microorganisms co-infections in human papillomaviruses infected women in Northern China

  2016cites this paper
• Human Papillomavirus Laboratory Testing: the Changing Paradigm

  2016cites this paper
• Human Papillomavirus Genotypes in Women Living with Human Immunodeficiency Virus Infection Attending Anti-Retroviral Therapy Clinic at the Korle-Bu Teaching Hospital, Accra

  2015cites this paper
• Oral Cytology for HIV

  2015cites this paper
• AIDS Care : Psychological and Socio-medical Aspects of AIDS / HIV

  2014cites this paper
• Improving cervical cancer screening rates in an urban HIV clinic

  2014cites this paper
• High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology

  2014cites this paper
• HIV associated high-risk HPV infection among Nigerian women

  2013cites this paper